Hormonal axes in obesity: Cause or effect?;Eixos hormonais na obesidade: Causa ou efeito?

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 51, Issue 1, 2007, Pages 34-41

  Lordelo, Roberta A ^a,b   Mancini, Marcio C ^a   Cercato, Cíntia ^a   Halpern, Alfredo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

ACTH; Endocrine axis; Estrogen; FSH; GH; Hormones; Leptin; LH; Obesity; Testosterone; TSH

Indexed keywords

CORTICOTROPIN; GONADOTROPIN; GROWTH HORMONE; HORMONE; LEPTIN; THYROTROPIN;

ENDOCRINE GLAND; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INSULIN RESISTANCE; METABOLISM; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ADRENOCORTICOTROPIC HORMONE; ENDOCRINE GLANDS; GONADOTROPINS, PITUITARY; GROWTH HORMONE; HORMONES; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INSULIN RESISTANCE; LEPTIN; OBESITY; THYROTROPIN;

EID: 34247171391     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302007000100007     Document Type: Review

References (56)

1. Rosmond R, Dallman MF, Björntorp P. Stress-related cortisol secretion in men: relationship with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J Clin Endocrinol Metab 1998;83(6):1853-9.
2. Pasquali R, Cantobelli S, Casimirri F, Capelli M, Bortoluzzi L, Flamia R et al. The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution. J Clin Endocrinol Metab 1993;77(2):341-6.
3. Rebuffe-Scrive M, Bronnegard M, Nilsso A, Eldh J, Gustafsson JA, Bjorntorp P. Steroid hormone receptors in human adipose tissues. J Clin Endocrinol Metab 1990;71:1215-9.
4. Bronnegard M, Arner P, Hellstrom Let, Akner G, Gustafsson JA. Glucocorticoid receptor messenger ribonucleic acid in different regions of human adipose tissue. Endocrinology 1990;127:1689-96.
5. Lottenberg SA, Giannella-Neto D, Derendorf H, Rocha M, Bosco A, Carvalho SV, et al. Effect of fat distribution on the pharmacokinetics of cortisol in obesity. Int J Clin Pharmacol Ther 1998;36(9):501-5.
6. Tales A, Graves L, Burke CW, Fotherby K, Fraser R. Free cortisol in obesity: effect of fasting. Acta Endocrinologica 1976;81(2):321-9.
7. Beauregard C, Dickstein G, Lacroix A. Classic and recent etiologies of Cushing syndrome: diagnosis and therapy. Treat Endocrinol 2002;1(2):79-94.
8. Arguello AMC, Cercato C, Barroso RL, et al. Urinary free cortisol levels in obese patients. Int J Obes Relat Metab Disord 2002;26(suppl. 1):S198.
9. Streeten DHP, Stevenson GT, Dalakos TG. The diagnosis of hypercortisolism: Biochemical criteria differentiating patients form lean and obese normal subjects and from females on oral contraceptives. J Clin Endocrinol Metab 1969;29:1191.
10. Strain GW, Zumoff B, Strain JJ. Cortisol production in obesity. Metabolism 1980;29:980-5.
11. Salehi M, Ferenczi A, Zumoff B. Obesity and cortisol status. Horm Metabol Res 2005;37(4):193-7.
12. Livingstone DE, Kenyon CJ, Walker BR. Mechanisms of dysregulation of 11 beta-hydroxysteroid dehydrogenase type 1 in obese Zucker rats. J Endocrinol 2000;167(3):533-9.
13. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, et al. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001;294(5549):2166-70.
14. Rask E, Olsson T, Soderberg S, Andrew R, Livingstone DE, Johnson O, et al. Tissue-specific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metab 2001;86(3):1418-21.
15. Engeli S, Bohnke J, Feldpausch M, Gorzelniak K, Heintze U, Janke J, et al. Regulation of 11beta-HSD genes in human adipose tissue: influence of central obesity and weight loss. Obes Res 2004;12(1):9-17.
16. Frish RE. Body fat, menarche, fitness and fertility. In: Frish RE (ed.). Adipose Tissue and Reproduction. Basel: S. Karger, 1990. pp. 1-26.
17. Chehab FF, Lim ME, Ronghue LL. Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat Genet 1996;12:318-20.
18. Foster DL, Nagatani S. Physiological perspectives on leptin as a regulator of reproduction: role in timing puberty. Biol Reprod 1999;60:205-15.
19. Kiess W, Reich A, Meyer K, Glasow A, Deutscher J, Klammt J, et al. A role for leptin in sexual maturation and puberty? Horm Res 1999;51(S3):55-63.
20. Roemmich JN, Rogol AD. Role of leptin during childhood growth and development. Endocrinol Metab Clin North Am 1999;28(4):749-64.
21. Glass AR, Swerdloff RS, Brady GA, Dahms WT, Atkinson RL. Low serum testosterone and sex hormone binding globulin in massively obese men. J Clin Endocrinol Metab 1977;45:1211-9.
22. Kopelman PG, White N, Pilkington TRE, Jeffcoate SL. The effect of weight loss on steroid secretion and binding in massively obese women. Clin Endocrinol 1981;14:113-6.
23. Lima N, Cavaliere H, Knobel M, Halpern A, Medeiros-Neto G. Decreased androgen levels in massively obese men may be associated with impaired function of the gonadostat. Int J Obes Relat Metab Disord 2000;24(11):1433-7.
24. Malacara JM, Fajardo ME, Nava LE. Gonadotropins at menopause: the influence of obesity, insulin resistance, and estrogens. Steroids 2001;66(7):559-67.
25. Kopelman PG. Hormones and obesity. Baillière's Clin Endocrinol Metab 1994;8(3):549-75.
26. Evans DJ, Hoffman RG, Kalkhoff R, Kissebah AH. Relationship of androgenic activity to body fat topography, fat cell morphology and metabolic aberrations in premenopausal women. J Clin Endocrinol Metab 1983;57:304-10.
27. Giagulli VA, Kaufman JM, Vermeulen A.Pathogenesis of decreased androgen levels in obese men. J Clin Endocrinol Metab 1994;79(4):997-1000.
28. Kopelman PG, Pilkington TRE, White N, Jeffcoate SL. Abnormal sex steroid secretion and binding in massively obese women. Clin Endocrinol 1980;12:363-9.
29. Meldrum DR, Davidson B J, Tataryn IV, Judd HL. Changes in circulating steroids with aging in post-menopausal women. Obstet Gynecol 1981;57:624-8.
30. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Hum Reprod 2004;19(1):41-7.
31. Dunaif A. Insulin resistance and the Polycystic Ovary Syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997;18(6):774-800.
32. Ehrmann DA. Polycystic Ovary Syndrome. N Engl J Med 2005;352:1223-36.
33. Spritzer PM, Poy M, Wiltgen D. Leptin concentrations in hirsute women with polycystic ovary syndrome or idiopathic hirsutism: influence on LH and relationship with hormonal, metabolic, and anthropometric measurements. Hum Rep 2001;16:1340-6.
34. Hoeger KM, Kochman L, Wixom N, Craig K, Miller RK, Guzick DS. A randomized, 48 week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study. Fertil Steril 2004;82:421-9.
35. Nestler JE, Jakubowicz DJ, Evans WS, Pasquali R. Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med 1998;338:1876-80.
36. Velazquez EM, Acosta A, Mendoza SG. Menstrual ciclicity after metformin therapy in polycystic ovary syndrome. Obstet Gynecol 1997;90:392-5.
37. Copinschi G, Wegienka LC, Hane S. Effect of arginine on serum levels of insulin and growth hormone in obese subjects. Metabolism 1967;16:485-91.
38. Bell JP, Donald RA, Espiner LA. Pituitary response to insulin-induced hypoglycemia in obese subjects before and after fasting. J Clin Endocrinol Metab 1970;31:546-51.
39. Cordido F, Penalva A, Dieguez C. Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity. J Clin Endocrinol Metab 1993;96:819-23.
40. Dieguez C, Carro E, Seoane L. Regulation of somatotroph cell function by the adipose tissue. Int J Obes 2000;24:S100-3.
41. Golay A, Swislocki ALM, Chen Y-DI, Jaspan JB, Reaven GM. Effect of obesity on ambient plasma glucose, free fatty acid, insulin, growth hormone and glucagon concentrations. J Clin Endocrinol Metab 1986;63:481-4.
42. Maccario M, Tassone F, Gauna C. Effects of short-term administration of low-dose rhGH on IGF-1 levels in obesity and Cushing's syndrome: indirect evaluation of sensitivity to GH. Eur J Endocrinol 2001;144:251-6.
43. Mancini MC, Costa APAC, Melo ME, Cercato C, Giannella-Neto D, Garrido Jr AB, et al. Effect of gastric bypass on spontaneus growth hormone and ghrelin release profiles. Obes Res 2006;14:383-7.
44. Glass AR. Endocrine aspects of obesity. Med Clin North Am 1989;73:139-60.
45. Gianotti L, Pivetti S, Lanfranco F, Tassone F, Navone E, Vittori R, et al. Concomitant impairment of growth hormone secretion and peripheral sensitivity in obese patients with obstructive sleep apnea syndrome. J Clin Endocrinol Metab 2002;87(11):5052-7.
46. Shadid S, Jensen MD. Effects of growth hormone administration in human obesity. Obes Res 2003;11(2):170-5.
47. Halpern A, Mancini MC, Cercato C, Villares SMF, Costa APAC. Efeito do hormônio do crescimento sobre parâmetros antropométricos e metabólicos na obesidade andróide. Arq Bras Endocrinol Metab 2006;50(1):68-73.
48. Moore R, Grant AN, Howard AM, Mills IH. Treatment of obesity with triodothyronine and a very-low calorie liquid formula diet. Lancet 1980;223-6.
49. Marcin Krotkiewski. Thyroid hormones in the pathogenesis and treatment of obesity. Eur J Pharmacol 2002;440:85-98.
50. Kralik A, Eder K, Kirchgessner M. Influence of zinc and selenium deficiency on parameters relating to thyroid hormone metabolism. Horm Metab Res 1996;28:223-6.
51. Krotkiewski M, Holm G, Shono N. Small dose of triiodothyronine can change some risk factors associated with abdominal obesity. Int J Obes 1997;21:922-9.
52. Krotkiewski M. Thyroid hormones in the pathogenesis and treatment of obesity. Eur J Pharmacol 2002;440:85-98.
53. Moulin de Moraes CM, Mancini MC, de Melo ME, Figueiredo DA, Villares SM, Rascovski A, et al. Prevalence of subclinical hypothyroidism in a morbidly obese population and improvement after weight loss induced by Roux-en-Y gastric bypass. Obes Surg 2005;15(9):1287-91.
54. Adsani H, Hoffer LJ, Silva JE. Resting energy expenditure is sensitive to small dose changes in patients on chronic thyroid hormone replacement. J Clin Endocrinol Metab 1997;82:1118-25.
55. Caraccio N, Ferrannini E, Monzani F. Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled study. J Clin Endocrinol Metab 2002;87:1533-8.
56. Iossa S, Lionetti L, Mollica MP, Crescenzo R, Barletta A, Liverini G. Fat balance and serum leptin concentration in normal, hypothyroid and hyperthyroid rats. Int J Obes 2001;25(3):417-25.